Large Cap Biotech Stocks Get Traction From Revenue Growth…Update-1
10/29/15 Update Large Cap Biotechs Update Amgen (AMGN) Revenues Grow 14%, beats street. 2016 Revenues guided to ~$22B, flattish revenue growth with higher EPS $10.35-$10.75. 2015 PEG=1.80, P/S=5.94, Div. 1.94% Rayno Biopharmaceutical Portfolio Large Caps up 2.6% YTD, IBB up 8% YTD REGN up 37%,...
Bio Investor Forum #2: Three Small Cap Biotech Stocks CRIS,GERN,OCRX…Update-1
Update-1… 11/9 Small Caps Outperform CRIS $2.62, GERN $3.92, OCRX $3.41 Bio Investor Forum-A Runway for Emerging Biotech Companies These are risky times for small cap biotech investments as you know the group took a big hit in July/August and are extremely volatile. Some of our smaller...
Bio Investor Forum 2015 #1 Notes-Policy and Venture Capital
General Issues from Bio Investor Forum See BIOtechNow for detailed articles on BIF#15 Biotech executives and investors came with a record 900 attendees to this annual event which presents key issues in the industry and offers a networking forum with 175 presenting companies to meet with...
Sector Shift Continues Out of Healthcare Stocks: Update-1
Summary for the Week of Oct 19:Markets Up on Central Banks Easing;Techs Lead the Way IBB up 0.62%- 316.3 bottomed on Wednesday. QQQ up 4.3%- 112.78 up big Thursday and Friday. XBI down o.58%- 65.67 in choppy trading. XLI up 4%- 54.66 steady climb from Monday. XLV down 0.62% 69.33 bottomed on...
Choppy Action Today in Biotech Stocks But Buyers Are Out There…Update-1
October 21 Update 9:45a EDT NASDAQ up 0.4% IBB up 1.57% 1:45p EDT Biotech Thrashing Continues-High Fliers Hit Hardest Healthcare stocks remain under attack with the XLV down 1.5% and the IBB down 1.6%.Healthcare is the sector loser down 2% while the Industrials are up slightly. Large cap...